Recommendations for inclusion in the Authorisation List

Recommendations for inclusion in the Authorisation List

Applications imbriquées

 

The REACH Regulation requires that ECHA recommends from the "Candidate List" priority substances for inclusion in Annex XIV (the "Authorisation List") to the European Commission, taking into account comments received from interested parties and the opinion of the Member State Committee. The European Commission finally decides, which substances will be included in Annex XIV and what the associated entries will be.

The below table includes all Candidate List substances that have been included in ECHA's draft or final recommendations for inclusion in Annex XIV. The "Status"- column indicates whether the substances have been included in a draft recommendation, recommended for inclusion or are already included in Annex XIV. Further details and documents relevant for the recommendations can be found by clicking on the "Details" next to the substances.

Substances not recommended in a given round (Status: “Not recommended in this round”) are re-assessed in subsequent rounds along with the other substances on the Candidate List. They may be included in future recommendations. Therefore, it is advisable to search the table by substance (Name/EC/CAS) to capture the most up-to-date status.
 

Recommendations for inclusion in the Authorisation List

Last updated 24 mai 2022. Database contains 111 unique substances/entries.
Filter the list
Intrinsic property
Date of final recommendation
Date of inclusion in the Authorisation List

The List does not contain any Substances.
 
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
400-600-6
71868-10-5
Toxic for reproduction (Article 57c)
11th recommendation
Included in draft recommendation
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
Toxic for reproduction (Article 57c)
11th recommendation
Included in draft recommendation
Details
show/hide
2-(4-tert-butylbenzyl)propionaldehyde EC No.: 201-289-8 | CAS No.: 80-54-6
(2S)-3-(4-tert-butylphenyl)-2-methylpropanal EC No.: - | CAS No.: 75166-30-2
(2R)-3-(4-tert-butylphenyl)-2-methylpropanal EC No.: - | CAS No.: 75166-31-3
799-970-2
-
Toxic for reproduction (Article 57c)
11th recommendation
Included in draft recommendation
Details
203-468-6
107-15-3
Respiratory sensitising properties (Article 57(f) - human health)
11th recommendation
Included in draft recommendation
Details
203-856-5
111-30-8
Respiratory sensitising properties (Article 57(f) - human health)
11th recommendation
Included in draft recommendation
Details
231-100-4
7439-92-1
Toxic for reproduction (Article 57c)
11th recommendation
Included in draft recommendation
Details
show/hide
Boric acid, sodium salt EC No.: 215-604-1 | CAS No.: 1333-73-9
Orthoboric acid, sodium salt EC No.: 237-560-2 | CAS No.: 13840-56-7
boric acid (H3BO3), sodium salt, hydrate EC No.: - | CAS No.: 25747-83-5
boric acid (H3BO3), sodium salt (1:1) EC No.: - | CAS No.: 14890-53-0
Boric acid (H3BO3), disodium salt EC No.: - | CAS No.: 22454-04-2
Trisodium orthoborate EC No.: 238-253-6 | CAS No.: 14312-40-4
799-969-7
-
Toxic for reproduction (Article 57c)
11th recommendation
Included in draft recommendation
Details
276-090-2
71850-09-4
Toxic for reproduction (Article 57c)
11th recommendation
Included in draft recommendation
Details
208-762-8
540-97-6
PBT (Article 57d)
vPvB (Article 57e)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
208-764-9
541-02-6
PBT (Article 57d)
vPvB (Article 57e)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
209-136-7
556-67-2
PBT (Article 57d)
vPvB (Article 57e)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
234-541-0
12008-41-2
Toxic for reproduction (Article 57c)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
209-008-0
552-30-7
Respiratory sensitising properties (Article 57(f) - human health)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
201-545-9
84-61-7
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - human health)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
262-967-7
61788-32-7
vPvB (Article 57e)
10th recommendation
Recommended for inclusion in Annex XIV
14-avr.-2021
Details
covering any of its individual anti- and syn-isomers or any combination thereof
-
-
vPvB (Article 57e)
9th recommendation
Recommended for inclusion in Annex XIV
01-oct.-2019
Details
209-218-2
561-41-1
Carcinogenic (Article 57a)
9th recommendation
Included in Annex XIV (Authorisation List)
01-oct.-2019
Details
201-245-8
80-05-7
Toxic for reproduction (Article 57c)
Endocrine disrupting properties (Article 57(f) - environment)
Endocrine disrupting properties (Article 57(f) - human health)
9th recommendation
Recommended for inclusion in Annex XIV
01-oct.-2019
Details
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
-
-
Endocrine disrupting properties (Article 57(f) - environment)
9th recommendation
Included in Annex XIV (Authorisation List)
01-oct.-2019
Details
-
-
Toxic for reproduction (Article 57c)
9th recommendation
Included in Annex XIV (Authorisation List)
01-oct.-2019
Details
239-622-4
15571-58-1
Toxic for reproduction (Article 57c)
9th recommendation
Included in Annex XIV (Authorisation List)
01-oct.-2019
Details
273-688-5
69011-06-9
Toxic for reproduction (Article 57c)
9th recommendation
Recommended for inclusion in Annex XIV
01-oct.-2019
Details
235-702-8
12578-12-0
Toxic for reproduction (Article 57c)
9th recommendation
Recommended for inclusion in Annex XIV
01-oct.-2019
Details
292-966-7
91031-62-8
Toxic for reproduction (Article 57c)
9th recommendation
Recommended for inclusion in Annex XIV
01-oct.-2019
Details
234-853-7
12036-76-9
Toxic for reproduction (Article 57c)
9th recommendation
Recommended for inclusion in Annex XIV
01-oct.-2019
Details

Export search results to:

EU Privacy Disclaimer

Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.